Gov. Larry Hogan will travel to Israel later this month in an effort to attract more overseas businesses to Maryland, particularly in the areas of biotechnology and cybersecurity.
The Biomedical Research Institute (BRI), founded in Rockville, MD in 1968, is a not-forprofit research institute that emphasizes basic research in schistosomiasis. BRI expanded its subsidiaries in 1985 to include the Association of Entrepreneurial Science (AES), an incubator for startup scientific companies that brings scientists and basic research findings into the realm of commercial markets. AES brings together all the accompanying business skills required for profit making entrepreneurs to bring scientific products and services to the marketplace.
D.C.-based Danaher Corp. (NYSE: DHR) is buying California molecular diagnostics company Cepheid Inc. (NASDAQ: CPHD) for about $4 billion in cash.
The $53 per share price represents a 54 percent premium on its Friday closing price of $34.42 per share. The deal, expected to close in the fourth quarter, would constitute a sizable addition to Danaher’s $8.2 billion life sciences and medical testing and equipment business.
The Next Phase of the FLC Awards is Here – 2017 FLC Awards
The 2017 FLC Awards is now open for nominations. One of the most coveted honors in the technology transfer field, the FLC awards have been presented to over 200 federal laboratories since their inception in 1984. Many of our winning technology transfer efforts have gone on to become products and devices that are indispensable in our daily lives.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
- Notice of NCCIH’s Participation in PA-16-414 “Innovation Corps (I-Corps) at NIH Program for NIH and CDC Phase I Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grantees (Admin Supp)”
- (NOT-AT-16-003)
- National Center for Complementary and Integrative Health
- Notice of Clarification to NHLBI’s Policy Regarding Total Years of Support for K24 Funding
- (NOT-HL-16-442)
- National Heart, Lung, and Blood Institute
- Notice of Technical Assistance Webinars for Human Heredity and Health in Africa (H3Africa) FOAs: RFA-RM-011, RFA-RM-012, RFA-RM-013, RFA-RM-014, RFA-RM-16-015, RFA-RM-016, and RFA-RM-017
- (NOT-RM-16-028)
- NIH Roadmap Initiatives
- Notice of New Expiration Date for RFA-RM-16-013 “Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Research Program (U01)”
- (NOT-RM-16-029)
- NIH Roadmap Initiatives
Requests for Applications:
- Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)
- (RFA-HL-17-022)
- National Heart, Lung, and Blood Institute
Opinions expressed by Forbes Contributors are their own. Creating a tech invention with global potential is an ambition that many of us harbor but only relatively few are able to actually achieve.
So for the co-creators of a device that monitors newborn baby vital signs and improves their chances of survival in parts of the developing world, the sense of achievement in getting their startup idea off the ground is bolstered further by a feeling of real pride in doing work that could save thousands of lives.
It’s time once again to pick the members of the tech community who should win a coveted Baltimore Innovation Award.
This is a chance to recognize organizations and individuals who are innovating and growing Baltimore’s tech community. See all of last year’s award winners here.
One of the great scientific challenges is to understand the human brain. Research teams around the world are gathering data at breakneck speed on everything from the brain’s connectome and the way it computes to the nature of brain disease and how it can be better diagnosed and treated.
Bertin launches the first digital Night Vision Device providing smart fusion for accurate threat and target. Developed in partnership with Photonis Technologies, FusionSight® is a world- first compact monocular that combines a low light full color image sensor with a thermal image sensor.
In addition to exploring existing drugs for multiple indications, United Therapeutics (UTHR) has been actively investing in research and development (or R&D) programs involving novel technologies. These are targeted toward pulmonary arterial hypertension (or PAH), cancer, and the orphan disease bronchopulmonary dysplasia (or BPD).